Washington, DC
Our headquarters in the US capital grants us a unique advantage in comprehending and navigating the intricacies of policy and regulatory matters, allowing us to deliver unparalleled insights on how these issues impact your investments and business decisions.
1401 New York Ave NW, Ste 600
Washington, DC 20005
202-449-9862
Our Latest Insights
What Investors Should Know About Washington’s First Corporate Practice of Medicine Bill
Capstone believes the Stop Corporate Takeovers of Physicians Act, the first corporate practice of medicine (CPOM) legislation at the federal level, marks a departure from CPOM’s history as a state-regulated matter. The bill is based on Oregon’s SB 951, a model...
The UK’s Public Control Push Creates Uncertainty for Utilities
UK utilities have faced intense public scrutiny in recent years due to outdated infrastructure, repeated environmental failures, and rising consumer bills. Utilities have, as a result, become highly politicised, with their private ownership status increasingly seen as...
Clinical Trials Face an Enrollment Problem; Washington Is Betting on AI
The second Trump administration is deeply supporting technology in healthcare, including in asking questions about how artificial intelligence (AI) could revolutionize trials. In clinical trials, the tech-forward shift began during the COVID-19 pandemic, when...


























